Stanley H. Appel
#99,810
Most Influential Person Now
Stanley H. Appel's AcademicInfluence.com Rankings
Stanley H. Appelphilosophy Degrees
Philosophy
#3864
World Rank
#6169
Historical Rank
Logic
#1466
World Rank
#2225
Historical Rank
Download Badge
Philosophy
Why Is Stanley H. Appel Influential?
(Suggest an Edit or Addition)Stanley H. Appel's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Exome sequencing in amyotrophic lateral sclerosis identifies risk genes and pathways (2015) (816)
- Prevalence and patterns of cognitive impairment in sporadic ALS (2005) (804)
- Natural history of amyotrophic lateral sclerosis in a database population. Validation of a scoring system and a model for survival prediction. (1995) (726)
- A unifying hypothesis for the cause of amyotrophic lateral sclerosis, parkinsonism, and alzheimer disease (1981) (707)
- Wild-type microglia extend survival in PU.1 knockout mice with familial amyotrophic lateral sclerosis (2006) (682)
- Mutant Mice (Quaking and Jimpy) with Deficient Myelination in the Central Nervous System (1964) (602)
- An antisense oligonucleotide against SOD1 delivered intrathecally for patients with SOD1 familial amyotrophic lateral sclerosis: a phase 1, randomised, first-in-man study (2013) (522)
- Presence of dendritic cells, MCP‐1, and activated microglia/macrophages in amyotrophic lateral sclerosis spinal cord tissue (2004) (510)
- Genome-wide Analyses Identify KIF5A as a Novel ALS Gene (2018) (414)
- Genome-wide Analyses Identify KIF5A as a Novel ALS Gene (2018) (414)
- Immune reactivity in a mouse model of familial ALS correlates with disease progression (2001) (411)
- CD4+ T cells support glial neuroprotection, slow disease progression, and modify glial morphology in an animal model of inherited ALS (2008) (402)
- Mutations in NR4A2 associated with familial Parkinson disease (2003) (386)
- Protein modification by the lipid peroxidation product 4‐hydroxynonenal in the spinal cords of amyotrophic lateral sclerosis patients (1998) (374)
- Clinical Phenotypes of Different MPZ (P0) Mutations May Include Charcot–Marie–Tooth Type 1B, Dejerine–Sottas, and Congenital Hypomyelination (1996) (367)
- Serum Globulin in Myasthenia Gravis: Inhibition of α-Bungarotoxin Binding to Acetylcholine Receptors (1974) (361)
- Minocycline inhibits microglial activation and protects nigral cells after 6-hydroxydopamine injection into mouse striatum (2001) (358)
- The role of calcium‐binding proteins in selective motoneuron vulnerability in amyotrophic lateral sclerosis (1994) (355)
- Transformation from a neuroprotective to a neurotoxic microglial phenotype in a mouse model of ALS (2012) (348)
- Safety and efficacy of eculizumab in anti-acetylcholine receptor antibody-positive refractory generalised myasthenia gravis (REGAIN): a phase 3, randomised, double-blind, placebo-controlled, multicentre study (2017) (341)
- Microglia in ALS: The Good, The Bad, and The Resting (2009) (330)
- Ultrastructural evidence for altered calcium in motor nerve terminals in amyotrophc lateral sclerosis (1996) (326)
- Endogenous regulatory T lymphocytes ameliorate amyotrophic lateral sclerosis in mice and correlate with disease progression in patients with amyotrophic lateral sclerosis (2011) (307)
- Increased lipid peroxidation in sera of ALS patients (2004) (296)
- Lymphocytic infiltrates in the spinal cord in amyotrophic lateral sclerosis. (1993) (280)
- Regulatory T-lymphocytes mediate amyotrophic lateral sclerosis progression and survival (2012) (269)
- Microglial Activation and Dopaminergic Cell Injury: An In Vitro Model Relevant to Parkinson's Disease (2001) (261)
- Prevalence and correlates of neuropsychological deficits in amyotrophic lateral sclerosis. (1996) (261)
- Immune-mediated Mechanisms in the Pathoprogression of Amyotrophic Lateral Sclerosis (2013) (256)
- Extracellular mutant SOD1 induces microglial‐mediated motoneuron injury (2010) (254)
- Blood–spinal cord barrier breakdown and pericyte reductions in amyotrophic lateral sclerosis (2012) (253)
- The application of tissue culture to the study of experimental, “allergic” encephalomyelitis: I. Patterns Of demyelination (1961) (251)
- Whole-genome analysis of sporadic amyotrophic lateral sclerosis. (2007) (239)
- T cell-microglial dialogue in Parkinson's disease and amyotrophic lateral sclerosis: are we listening? (2010) (233)
- Acetylcholine receptor antibodies in myasthenia gravis. (1975) (229)
- Forced vital capacity (FVC) as an indicator of survival and disease progression in an ALS clinic population (2005) (227)
- A rating scale for amyotrophic lateral sclerosis: Description and preliminary experience (1987) (226)
- TREM2 variant p.R47H as a risk factor for sporadic amyotrophic lateral sclerosis. (2014) (225)
- IgG reactivity in the spinal cord and motor cortex in amyotrophic lateral sclerosis. (1990) (222)
- Reduction of naturally occurring motoneuron death in vivo by a target-derived neurotrophic factor. (1988) (219)
- Protective and Toxic Neuroinflammation in Amyotrophic Lateral Sclerosis (2015) (217)
- Biochemical studies of synapses in vitro. I. Protein synthesis. (1968) (208)
- Serum antibodies to L-type calcium channels in patients with amyotrophic lateral sclerosis. (1992) (207)
- A randomized, placebo-controlled trial of topiramate in amyotrophic lateral sclerosis (2003) (199)
- Reduced Nurrl Expression Increases the Vulnerability of Mesencephalic Dopamine Neurons to MPTP‐Induced Injury (1999) (193)
- Treatment of pseudobulbar affect in ALS with dextromethorphan/quinidine (2004) (188)
- A study comparing patients with amyotrophic lateral sclerosis and their caregivers on measures of quality of life, depression, and their attitudes toward treatment options (2003) (175)
- The chemokine MCP-1 and the dendritic and myeloid cells it attracts are increased in the mSOD1 mouse model of ALS (2006) (173)
- The Microglial-Motoneuron dialogue in ALS (2011) (168)
- Neuroinflammation modulates distinct regional and temporal clinical responses in ALS mice (2011) (166)
- Protective role of heme oxygenase‐1 in oxidative stress‐induced neuronal injury (1999) (164)
- A placebo‐controlled, double‐blind, randomized, two‐center, pilot trial of Cop 1 in chronic progressive multiple sclerosis (1991) (164)
- Role of Potassium Channels in Amyloid‐Induced Cell Death (1998) (159)
- Mutant SOD1G93A microglia are more neurotoxic relative to wild‐type microglia (2007) (158)
- Fragmentation of the Golgi apparatus of motor neurons in amyotrophic lateral sclerosis. (1992) (158)
- Protective effects of an anti‐inflammatory cytokine, interleukin‐4, on motoneuron toxicity induced by activated microglia (2006) (155)
- Deciphering amyotrophic lateral sclerosis: What phenotype, neuropathology and genetics are telling us about pathogenesis (2013) (155)
- THE APPLICATION OF TISSUE CULTURE TO THE STUDY OF EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS (1964) (153)
- Immune dysregulation in amyotrophic lateral sclerosis: mechanisms and emerging therapies (2019) (152)
- Activated Microglia Initiate Motor Neuron Injury by a Nitric Oxide and Glutamate‐Mediated Mechanism (2004) (150)
- TDP-43 Depletion in Microglia Promotes Amyloid Clearance but Also Induces Synapse Loss (2017) (148)
- Selective Agenesis of Mesencephalic Dopaminergic Neurons in Nurr1-Deficient Mice (1999) (144)
- Cell death induced by β-amyloid 1–40 in MES 23.5 hybrid clone: the role of nitric oxide and NMDA-gated channel activation leading to apoptosis (1995) (144)
- Intracellular Calcium Parallels Motoneuron Degeneration in SOD-1 Mutant Mice (1998) (141)
- Parvalbumin overexpression alters immune‐mediated increases in intracellular calcium, and delays disease onset in a transgenic model of familial amyotrophic lateral sclerosis (2001) (139)
- Accelerated degradation of acetylcholine receptor from cultured rat myotubes with myasthenia gravis sera and globulins. (1977) (139)
- TISSUE CULTURE STUDIES OF DEMYELINATION * (1965) (138)
- Prognosis of amyotrophic lateral sclerosis and the effect of referral selection (1995) (136)
- Membrane protein kinase alteration in Duchenne muscular dystrophy (1975) (135)
- TDP-43 activates microglia through NF-κB and NLRP3 inflammasome (2015) (135)
- Subcutaneous IGF-1 is not beneficial in 2-year ALS trial (2008) (134)
- Role of nitric oxide in rotenone‐induced nigro‐striatal injury (2003) (133)
- Soluble striatal extracts enhance development of mesencephalic dopaminergic neurons in vitro (1986) (124)
- Cytotoxicity of immunoglobulins from amyotrophic lateral sclerosis patients on a hybrid motoneuron cell line. (1994) (121)
- DECREASED mRNA EXPRESSION OF TIGHT JUNCTION PROTEINS IN LUMBAR SPINAL CORDS OF PATIENTS WITH ALS (2009) (120)
- ALS patients' regulatory T lymphocytes are dysfunctional, and correlate with disease progression rate and severity. (2017) (119)
- Immunoglobulins from animal models of motor neuron disease and from human amyotrophic lateral sclerosis patients passively transfer physiological abnormalities to the neuromuscular junction. (1991) (114)
- Regulatory T lymphocytes from ALS mice suppress microglia and effector T lymphocytes through different cytokine-mediated mechanisms (2012) (114)
- Complement C3c and related protein biomarkers in amyotrophic lateral sclerosis and Parkinson's disease. (2006) (113)
- Effect of diphenylhydantoin on synaptosome sodium-potassium-ATPase. (1968) (113)
- Frontal‐lobe mediated behavioral dysfunction in amyotrophic lateral sclerosis (2010) (112)
- Oxidative Stress: a common denominator in the pathogenesis of amyotrophic lateral sclerosis (2003) (111)
- Incidence and prevalence of amyotrophic lateral sclerosis in Harris County, Texas, 1985-1988. (1991) (111)
- Hippocampal cholinergic neurostimulating peptides (HCNP) (2000) (107)
- Amyotrophic lateral sclerosis: early predictors of prolonged survival (2006) (106)
- Amyotrophic lateral sclerosis. Associated clinical disorders and immunological evaluations. (1986) (105)
- Protein kinase activity in erythrocyte ghosts of patients with myotonic muscular dystrophy. (1973) (105)
- Experimental destruction of substantia nigra initiated by Parkinson disease immunoglobulins. (1998) (104)
- IgG from amyotrophic lateral sclerosis patients increases current through P-type calcium channels in mammalian cerebellar Purkinje cells and in isolated channel protein in lipid bilayer. (1993) (102)
- Mutations in NR4A2 associated with familial Parkinson disease (2003) (101)
- Erythrocyte protein phosphorylation. (1973) (100)
- Neuroprotection by pramipexole against dopamine- and levodopa-induced cytotoxicity. (1999) (100)
- Characterization of Gene Expression Phenotype in Amyotrophic Lateral Sclerosis Monocytes (2017) (98)
- Spin label study of erythrocyte membrane fluidity in myotonic and Duchenne muscular dystrophy and congenital myotonia (1976) (98)
- Antioxidant property of pramipexole independent of dopamine receptor activation in neuroprotection (2000) (94)
- Antibodies to calcium channels from ALS patients passively transferred to mice selectively increase intracellular calcium and induce ultrastructural changes in motoneurons (1995) (94)
- Expression of calbindin-D28K in motoneuron hybrid cells after retroviral infection with calbindin-D28K cDNA prevents amyotrophic lateral sclerosis IgG-mediated cytotoxicity. (1996) (93)
- Biochemical studies of synapses in vitro. 3. Ionic activation of protein synthesis. (1969) (93)
- Expanded autologous regulatory T-lymphocyte infusions in ALS (2018) (91)
- Phosphorylation of myelin basic protein. (1974) (86)
- Neuroinflammatory mechanisms in amyotrophic lateral sclerosis pathogenesis (2018) (85)
- CD4+ T cells mediate cytotoxicity in neurodegenerative diseases. (2008) (85)
- Selective effects of skeletal muscle extract fractions on motoneuron development in vitro (1986) (85)
- Interaction of myasthenic serum globulin with the acetylcholine receptor. (1975) (84)
- A double-blind study of the effectiveness of cyclosporine in amyotrophic lateral sclerosis. (1988) (84)
- A generalized disorder of nervous system, skeletal muscle and heart resembling Refsum's disease and Hurler's syndrome. I. Clinical, pathologic and biochemical characteristics. (1967) (84)
- Calpain activation in apoptosis of ventral spinal cord 4.1 (VSC4.1) motoneurons exposed to glutamate: Calpain inhibition provides functional neuroprotection (2005) (83)
- Slower disease progression and prolonged survival in contemporary patients with amyotrophic lateral sclerosis: is the natural history of amyotrophic lateral sclerosis changing? (2006) (83)
- Electron spin resonance studies of membrane proteins in erythrocytes in myotonic muscular dystrophy. (1976) (82)
- Carrier detection in Duchenne muscular dystrophy. (1976) (82)
- Amyotrophic lateral sclerosis patient antibodies label Ca2+ channel α1 subunit (1994) (82)
- Role of Fcγ Receptors in Nigral Cell Injury Induced by Parkinson Disease Immunoglobulin Injection into Mouse Substantia Nigra (2002) (81)
- Promoting excellence in end‐of‐life care in ALS (2005) (80)
- Immunoglobulin Fcγ receptor promotes immunoglobulin uptake, immunoglobulin‐mediated calcium increase, and neurotransmitter release in motor neurons (2002) (80)
- Scanning electron microscopy studies in muscular dystrophy. (1976) (78)
- Neurotrophic effects of hippocampal extracts on medial septal nucleus in vitro. (1984) (78)
- Experimental autoimmune motoneuron disease (1989) (78)
- Quality of life in patients with amyotrophic lateral sclerosis: perceptions, coping resources, and illness characteristics. (2003) (77)
- A SPECTROPHOTOMETRIC ASSAY FOR THIOGALACTOSIDE TRANSACETYLASE. (1965) (76)
- A comparative electron spin resonance study of the erythrocyte membrane in myotonic muscular dystrophy. (1974) (76)
- Evidence for autoimmunity in amyotrophic lateral sclerosis (1994) (76)
- Purification of a skeletal muscle polypeptide which stimulates choline acetyltransferase activity in cultured spinal cord neurons. (1988) (76)
- TDP-43 pathology in the basal forebrain and hypothalamus of patients with amyotrophic lateral sclerosis (2014) (75)
- Decremental motor responses to repetitive nerve stimulation in ALS (1994) (74)
- Myotonic muscular dystrophy: altered calcium transport in erythrocytes. (1978) (74)
- Toward more efficient clinical trials for amyotrophic lateral sclerosis (2010) (74)
- Selegiline is ineffective in a collaborative double-blind, placebo-controlled trial for treatment of amyotrophic lateral sclerosis. (1998) (73)
- Randomized phase 2 trial of NP001–a novel immune regulator: Safety and early efficacy in ALS (2015) (73)
- Macromolecular characterization of muscle membranes. I. Proteins and sialic acid of normal and denervated muscle. (1973) (73)
- Serum C-Reactive Protein as a Prognostic Biomarker in Amyotrophic Lateral Sclerosis (2017) (72)
- Excitotoxic neuronal cell death in amyotrophic lateral sclerosis (1993) (71)
- Epigallocatechin gallate prevents oxidative-stress-induced death of mutant Cu/Zn-superoxide dismutase (G93A) motoneuron cells by alteration of cell survival and death signals. (2004) (71)
- Amyotrophic lateral sclerosis immunoglobulins increase Ca2+ currents in a motoneuron cell line (1995) (70)
- 1α, 25 dihydroxyvitamin D3‐dependent up‐regulation of calcium‐binding proteins in motoneuron cells (1998) (70)
- Brain choline acetyltransferase and mental function in Alzheimer disease. (1999) (70)
- Purification and kinetic properties of brain orotidine 5'-phosphate decarboxylase. (1968) (68)
- Biochemical studies of synapses in vitro. II. Potassium transport. (1969) (66)
- Calcium: the Darth Vader of ALS (2001) (66)
- Antibodies from patients with Parkinson's disease react with protein modified by dopamine oxidation (1998) (63)
- Electron spin resonance studies of erythrocytes from patients with myotonic muscular dystrophy. (1974) (63)
- Motor neuron destruction in guinea pigs immunized with bovine spinal cord ventral horn homogenate: experimental autoimmune gray matter disease (1990) (63)
- Widespread increased expression of the DNA repair enzyme PARP in brain in ALS (2004) (62)
- Cognitive impairment in familial ALS (2007) (61)
- Apoptotic Cell Death of a Hybrid Motoneuron Cell Line Induced by Immunoglobulins from Patients with Amyotrophic Lateral Sclerosis (1994) (60)
- Evidence for autoimmunity in amyotrophic lateral sclerosis (1993) (60)
- Excess Circulating Alternatively Activated Myeloid (M2) Cells Accelerate ALS Progression While Inhibiting Experimental Autoimmune Encephalomyelitis (2011) (59)
- Scientific approaches to clinical neurology (1977) (59)
- Immunoglobulins from amyotrophic lateral sclerosis patients enhance spontaneous transmitter release from motor-nerve terminals. (1988) (59)
- Attenuation of the neurotoxic effect of Aβ amyloid peptide by apolipoprotein E (1994) (59)
- Trophic effects of skeletal muscle extracts on ventral spinal cord neurons in vitro: separation of a protein with morphologic activity from proteins with cholinergic activity (1985) (59)
- Predictability of disease progression in amyotrophic lateral sclerosis (2006) (58)
- Immunotherapy for neurological diseases. (2008) (55)
- Inhibition of brain protein synthesis: an approach to the biochemical basis of neurological dysfunction in the amino-acidurias. (1966) (54)
- HFE mutations are not strongly associated with sporadic ALS (2004) (54)
- Adult-onset combined methylmalonic aciduria and homocystinuria (cblC) (2001) (53)
- Defining SOD1 ALS natural history to guide therapeutic clinical trial design (2016) (53)
- PARP Expression Is Increased in Astrocytes but Decreased in Motor Neurons in the Spinal Cord of Sporadic ALS Patients (2003) (52)
- Clinical Significance of TDP-43 Neuropathology in Amyotrophic Lateral Sclerosis (2017) (52)
- Brain Polysomes: Response to Environmental Stimulation (1967) (51)
- Wheelchair use by patients with amyotrophic lateral sclerosis: a survey of user characteristics and selection preferences. (2001) (51)
- Erratum: Mutations in NR4A2 associated with familial Parkinson disease (Nature Genetics (2003) 33 (85-89)) (2003) (51)
- Effects of cerebrospinal fluid from patients with Parkinson disease on dopaminergic cells. (1999) (49)
- Synthesis de novo of purines in slices of rat brain and liver 1 (1970) (49)
- Major stressors facing patients with amyotrophic lateral sclerosis (ALS): a survey to identify their concerns and to compare with those of their caregivers (2004) (49)
- β‐Amyloid‐Induced Neurotoxicity of a Hybrid Septal Cell Line Associated with Increased Tau Phosphorylation and Expression of β‐Amyloid Precursor Protein (1997) (49)
- Acetylcholine receptor in normal and denervated slow and fast muscle. (1974) (49)
- Neurotoxicity of Aβ amyloid protein in vitro is not altered by calcium channel blockade (1995) (49)
- Regulation of acetylcholine receptor by cyclic AMP. (1980) (48)
- Long-term neuromuscular dysfunction produced by passive transfer of amyotrophic lateral sclerosis immunoglobulins (1992) (48)
- 2D gel blood serum biomarkers reveal differential clinical proteomics of the neurodegenerative diseases (2006) (48)
- Phosphorylated TDP-43 (pTDP-43) aggregates in the axial skeletal muscle of patients with sporadic and familial amyotrophic lateral sclerosis (2018) (47)
- Erythrocyte spectrin peak II phosphorylation in Duchenne muscular dystrophy (1976) (46)
- Red blood cell alterations in muscular dystrophy: The role of lipids (1980) (46)
- Cholinergic sites in skeletal muscle. I. Denervation effects. (1976) (45)
- Increased intracellular calcium triggered by immune mechanisms in amyotrophic lateral sclerosis. (1995) (44)
- Resistance of extraocular motoneuron terminals to effects of amyotrophic lateral sclerosis sera (2000) (44)
- Altered Calcium Homeostasis and Ultrastructure in Motoneurons of Mice Caused by Passively Transferred Anti‐motoneuronal IgG (1997) (43)
- Autoimmunity and ALS (1996) (42)
- Cultured muscle from myotonic muscular dystrophy patients: altered membrane electrical properties. (1981) (40)
- Increased phosphorylated components of erythrocyte membrane spectrin band II with reference to Duchenne muscular dystrophy (1976) (40)
- Kinetic studies on rat liver carbamyl phosphate synthetase. (1968) (40)
- Oral tetrahydroaminoacridine in the treatment of senile dementia, Alzheimer's type. (1987) (40)
- Head-to-Head Comparison of 11C-PBR28 and 18F-GE180 for Quantification of the Translocator Protein in the Human Brain (2018) (40)
- (−)-Deprenyl protection of 1-methyl-4 phenylpyridium ion (MPP+)-induced apoptosis independent of MAO-B inhibition (1997) (40)
- The specificity and cross-reactivity of antisynaptosome antibodies as determined by sequential adsorption analysis. (1971) (40)
- A robust, good manufacturing practice-compliant, clinical-scale procedure to generate regulatory T cells from patients with amyotrophic lateral sclerosis for adoptive cell therapy. (2016) (38)
- Peripheral nerve inflammation in ALS mice: cause or consequence (2012) (38)
- Zonal centrifuge profiles of rat brain homogenates: instability in sucrose, stability in iso-osmotic Ficoll-sucrose. (1971) (38)
- ALSFRS and appel ALS scores: Discordance with disease progression (2008) (37)
- Trophic effect of angiotensin II, vasopressin and other peptides on the cultured ventral spinal cord of rat embryo (1991) (36)
- Functional alterations of myeloid cells during the course of Alzheimer’s disease (2018) (36)
- Amyotrophic Lateral Sclerosis Immunoglobulins Increase Intracellular Calcium in a Motoneuron Cell Line (1997) (36)
- Trophic factors in neurologic disease. (1988) (34)
- The action of amyotrophic lateral sclerosis immunoglobulins on mammalian single skeletal muscle Ca2+ channels. (1993) (34)
- IgG from amyotrophic lateral sclerosis affects tubular calcium channels of skeletal muscle. (1991) (34)
- Use of [3H]-GBR12935 to measure dopaminergic nerve terminal growth into the developing rat striatum. (1992) (34)
- Neuroprotective activities of regulatory T cells. (2011) (33)
- Autoantibodies to acetylcholine receptors in myasthenia gravis. (1983) (33)
- Effect of Inhibition of RNA Synthesis on Neural Information Storage (1965) (33)
- Apolipoprotein E ɛ4 in bulbar-onset motor neuron disease (1996) (33)
- Mutant genes responsible for Parkinson's disease. (2004) (33)
- Head-to-head comparison of 11C-PBR28 and 11C-ER176 for quantification of the translocator protein in the human brain (2019) (32)
- Turnover of Brain Messenger RNA (1967) (32)
- Phase IIa trial of fingolimod for amyotrophic lateral sclerosis demonstrates acceptable acute safety and tolerability (2017) (32)
- TREM 2 Variant p . R 47 H as a Risk Factor for Sporadic Amyotrophic Lateral Sclerosis (2014) (31)
- Incidence and Characteristics of Spinal Decompression Surgery after the Onset of Symptoms of Amyotrophic Lateral Sclerosis (2005) (31)
- Nigral damage and dopaminergic hypofunction in mesencephalon‐immunized guinea pigs (1992) (30)
- Distinct influences of nerve growth factor and a central cholinergic trophic factor on medial septal explants (1987) (30)
- Autoimmunity as an etiological factor in sporadic amyotrophic lateral sclerosis. (1995) (29)
- Isolation and characterization of the surface membranes of fast and slow mammalian skeletal muscle. (1977) (29)
- Phosphorylation of Muscle Membranes: Identification of a Membrane-Bound Protein Kinase (1973) (29)
- The effect of calcium on acetylcholine receptor synthesis (1981) (28)
- An open-label multicenter study to assess the safety of dextromethorphan/quinidine in patients with pseudobulbar affect associated with a range of underlying neurological conditions (2014) (28)
- MYELIN BASIC PROTEIN PHOSPHATASE ACTIVITY IN RAT BRAIN (1977) (28)
- Serum anti-Fas antibody levels in amyotrophic lateral sclerosis (2003) (28)
- Inflammation in Parkinson's disease: Cause or consequence? (2012) (28)
- Experimental autoimmune nigral damage in guinea pigs (1995) (28)
- Organization of acetylcholine receptor clusters in cultured rat myotubes is calcium dependent (1984) (28)
- Phenytoin and membrane fluidity in myotonic dystrophy. (1975) (27)
- T Cell Receptor BV Gene Rearrangements in the Spinal Cords and Cerebrospinal Fluid of Patients with Amyotrophic Lateral Sclerosis (1999) (27)
- Macromolecular characterization of muscle membranes. Endogenous membrane kinase and phosphorylated protein substrate from normal and denervated muscle. (1975) (27)
- Cholinergic Sites in Skeletal Muscle (1976) (26)
- Autoimmunity and ALS: a comparison of animal models of immune-mediated motor neuron destruction and human ALS. (1991) (26)
- Neurological Mutants of the Mouse. (1965) (26)
- An open label study of a novel immunosuppression intervention for the treatment of amyotrophic lateral sclerosis (2018) (26)
- Human Bone Marrow Endothelial Progenitor Cell Transplantation into Symptomatic ALS Mice Delays Disease Progression and Increases Motor Neuron Survival by Repairing Blood-Spinal Cord Barrier (2019) (26)
- Dipeptide repeat (DPR) pathology in the skeletal muscle of ALS patients with C9ORF72 repeat expansion (2019) (25)
- Restoring regulatory T-cell dysfunction in Alzheimer’s disease through ex vivo expansion (2020) (25)
- Inhibitors of membrane depolarization regulate acetylcholine receptor synthesis by a calcium-dependent, cyclic nucleotide-independent mechanism. (1982) (25)
- Endogenous Inhibitor of Ligand Binding to the Muscarinic Acetylcholine Receptor (1985) (24)
- Characterization of the beta-adrenergic receptor and adenylate cyclase in skeletal muscle plasma membranes. (1978) (24)
- Association between dysarthria and cognitive impairment in ALS: A prospective study (2010) (23)
- Increased activation ability of monocytes from ALS patients (2020) (23)
- Experimental immune-mediated damage of septal cholinergic neurons (1997) (22)
- Macromolecular characterization of muscle membranes. Acetylcholine receptor of normal and denervated muscle. (1974) (22)
- Experimental immune-mediated motor neuron diseases: Models for human ALS (1993) (22)
- Elevated acute phase proteins reflect peripheral inflammation and disease severity in patients with amyotrophic lateral sclerosis (2020) (21)
- Activated microglia: The silent executioner in neurodegenerative disease? (2001) (21)
- Increased CSF glutamate following injection of ALS immunoglobulins (1997) (20)
- Is ALS a systemic disorder? Evidence from muscle mitochondria (2006) (20)
- Stereotaxic injection of IgG from patients with Alzheimer disease initiates injury of cholinergic neurons of the basal forebrain. (2000) (20)
- Immunosuppressive Functions of M2 Macrophages Derived from iPSCs of Patients with ALS and Healthy Controls (2020) (20)
- Abnormal serum concentrations of proteins in Parkinson's disease. (2009) (20)
- β‐Amyloid1–40 Increases Expression of β‐Amyloid Precursor Protein in Neuronal Hybrid Cells (1995) (20)
- The Role of Regulatory T Lymphocytes in Amyotrophic Lateral Sclerosis. (2018) (19)
- The value of database controls in pilot or futility studies in ALS (2006) (19)
- Phenotypic characteristics of human bone marrow-derived endothelial progenitor cells in vitro support cell effectiveness for repair of the blood-spinal cord barrier in ALS (2019) (19)
- Attenuation of the neurotoxic effect of A beta amyloid peptide by apolipoprotein E. (1994) (18)
- Effects of denervation on glycoproteins of rabbit gastrocnemius and soleus muscles. (1973) (18)
- Properties and distribution of mammalian skeletal muscle guanylate cyclase. Alterations in denervated and dystrophic muscle. (1978) (18)
- Transplantation of human bone marrow stem cells into symptomatic ALS mice enhances structural and functional blood-spinal cord barrier repair (2018) (18)
- Ex vivo expansion of dysfunctional regulatory T lymphocytes restores suppressive function in Parkinson’s disease (2021) (18)
- Development of denervation alterations in surface membranes of mammalian skeletal muscle (1977) (18)
- Biochemical studies of transneuronal degeneration: the effects of enucleation on the biochemical maturation of the chick optic tectum. (1974) (17)
- Introduction to supplement: the current status of treatment for ALS (2017) (17)
- Apolipoprotein E epsilon 4 in bulbar-onset motor neuron disease. (1996) (17)
- Apoptosis induced by β-N-oxalylamino-l-alanine on a motoneuron hybrid cell line (1996) (17)
- β-Adrenergic receptor-adenylate cyclase of denervated sarcolemmal membrane (1978) (17)
- Sublethal dose of 4-hydroxynonenal reduces intracellular calcium in surviving motor neurons in vivo (2005) (17)
- Purification and Characterization of a Central Cholinergic Enhancing Factor from Rat Brain: Its Identity as Phosphoethanolamine (1989) (17)
- Developmental discord among markers for cholinergic differentiation: in vitro time courses for early expression and responses to skeletal muscle extract. (1988) (16)
- Altered calcium homeostasis in spinal motoneurons but not in oculomotor neurons of SOD-1 knockout mice (2000) (16)
- Increased MEPP frequency as an early sign of experimental immune‐mediated motoneuron disease (1990) (16)
- Myasthenic globulin enhances the loss of acetylcholine receptor clusters. (1983) (16)
- Cholinergic sites in skeletal muscle. II. Interaction of an agonist and two antagonists with the acetylcholine site. (1976) (16)
- Denervation alterations in surface membrane glycoprotein glycosyltransferases of mammalian skeletal muscle (1978) (16)
- Immune-mediated cell death in neurodegenerative disease. (1996) (15)
- Neuronal recognition and synaptogenesis (1975) (15)
- Neuroinflammation is highest in areas of disease progression in semantic dementia. (2021) (15)
- Mechanisms of disease pathogenesis in amyotrophic lateral sclerosis. A central role for calcium. (2002) (15)
- Neurodegenerative Disease: Autoimmunity Involving Calcium Channels a (1994) (14)
- Catalog of the Neurological Mutants of the Mouse (2014) (14)
- Inherited Membrane Disorders of Muscle: Duchenne Muscular Dystrophy and Myotonic Muscular Dystrophy (1978) (14)
- Choice reaction time modifiability in dementia and depression. (1985) (14)
- Fab fragments from amyotrophic lateral sclerosis IgG affect calcium channels of skeletal muscle. (1993) (14)
- Amyotrophic lateral sclerosis is a systemic disease: peripheral contributions to inflammation-mediated neurodegeneration (2021) (14)
- Motor neuron reactivity of sera from animals with autoimmune models of motor neuron destruction (1990) (13)
- Cyclophosphamide alters the clinical and pathological expression of experimental autoimmune gray matter disease (1991) (13)
- Diphenylhydantoin and potassium transport in isolated nerve terminals. (1971) (13)
- Pyrimethamine significantly lowers cerebrospinal fluid Cu/Zn superoxide dismutase in amyotrophic lateral sclerosis patients with SOD1 mutations (2017) (13)
- Phosphatidyl inositol turnover in muscle membranes following denervation 1 (1974) (13)
- Can Neurotrophic Factors Prevent or Reverse Motoneuron Injury in Amyotrophic Lateral Sclerosis? (1993) (13)
- Pyrimethamine Significantly Lowers CSF/SOD1 in ALS Patients With SOD1 Mutations (2017) (13)
- Neurologic complications of renal failure (1981) (13)
- Brain synapses. An in vitro model for the study of seizures. (1972) (13)
- Seeking a measure of clinically meaningful change in ALS (2014) (12)
- Calcium-containing endosomes at oculomotor terminals in animal models of ALS. (1999) (12)
- Methylation of erythrocyte membrane phospholipids in patients with myotonic and Duchenne muscular dystrophy (1980) (12)
- Is there acetylcholine receptor in human thymus? (1977) (12)
- Electrophysiology of human muscle in culture (1981) (11)
- Inhibition of Brain Protein Synthesis (1970) (11)
- Altered muscle calcium channel binding kinetics in autoimmune motoneuron disease (1995) (11)
- Beta-amyloid-induced neurotoxicity of a hybrid septal cell line associated with increased tau phosphorylation and expression of beta-amyloid precursor protein. (1997) (11)
- “Individual and health-related quality of life assessment in amyotrophic lateral sclerosis patients and their caregivers” by Lo Coco G, Lo Coco D, Cicero V, Oliveri A, Lo Verso G, Piccolo F, La Bella V (2005) (10)
- Theories of Causation (1995) (10)
- University of Dundee TDP-43 Depletion in Microglia Promotes Amyloid Clearance but Also Induces Synapse (9)
- Interaction of myasthenic immunoglobulins and cholinergic agonists on acetylcholine receptors of rat myotubes (1982) (9)
- Trophic effects of skeletal muscle extracts on spinal cord cultures. (1989) (9)
- Phosphoethanolamine Enhances High‐Affinity Choline Uptake and Acetylcholine Synthesis in Dissociated Cell Cultures of the Rat Septal Nucleus (1992) (9)
- Demyelination in cultures of rat cerebellum produced by experimental allergic encephalomyelitic serum. (1959) (9)
- Muscle-derived trophic factors influencing cholinergic neurons in vitro and in vivo. (1989) (8)
- Stem cells in amyotrophic lateral sclerosis (2016) (8)
- Altered calcium homeostasis in ALS as a target for therapy. (2000) (8)
- Letter: Erythrocytes in human muscular dystrophy. (1975) (8)
- beta-Amyloid1-40 increases expression of beta-amyloid precursor protein in neuronal hybrid cells. (1995) (7)
- Trauma, TDP‐43, and amyotrophic lateral sclerosis (2010) (7)
- Ultrastructural evidence of calcium involvement in experimental autoimmune gray matter disease (2000) (7)
- The biologic half-life of brain-localized antisynapse radioantibodies. (1970) (7)
- Modulation of septal cell activity by extracellular zinc (1997) (7)
- Immunization of guinea pigs with human choline acetyltransferase induces selective lower motoneuron destruction (1997) (7)
- Immunopathologic events at the endplate in myasthenia gravis (1985) (7)
- The effects of electrically induced seizures on potassium transport within isolated nerve terminals. (1970) (6)
- Modulation of acetylcholine release in rat hippocampus by amino alcohols and Bay K 8644 (1993) (6)
- MULTIPLE MOLECULAR FORMS OF BETA-GALACTOSIDASE. (1965) (6)
- Fast Progression in Amyotrophic Lateral Sclerosis Is Associated With Greater TDP-43 Burden in Spinal Cord (2021) (6)
- Multimodal 18F-AV-1451 and MRI Findings in Nonfluent Variant of Primary Progressive Aphasia: Possible Insights on Nodal Propagation of Tau Protein Across the Syntactic Network (2019) (6)
- Phosphorylation of component a of the human erythrocyte membrane in myotonic muscular dystrophy (1975) (6)
- Extracellular Vesicles Derived From Ex Vivo Expanded Regulatory T Cells Modulate In Vitro and In Vivo Inflammation (2022) (6)
- Amino alcohol modulation of hippocampal acetylcholine release. (1992) (6)
- Immune-mediated models of motor neuron destruction in the guinea pig. (1991) (5)
- Differential morphologic effects of two fractions from fetal calf muscle on cultured chick ciliary ganglion cells. (1985) (5)
- The immune system continues to knock at the ALS door (2016) (5)
- Restricted T-cell receptor usage in spinal cord and brain of patients with amyotrophic lateral sclerosis (1991) (5)
- Erratum: Regulatory T-lymphocytes mediate amyotrophic lateral sclerosis progression and survival [EMBO Mol Med 5, 1] DOI: 10.1002/emmm.201201544 (2013) (5)
- Trophic Factors in Brain Aging and Disease (1985) (5)
- THE EFFECTS OF CARBAMYLCHOLINE, CALCIUM, AND CYCLIC NUCLEOTIDES ON ACETYLCHOLINE RECEPTOR SYNTHESIS IN CULTURED MYOTUBES * (1981) (5)
- Biochemical dysfunction and dementia. (1971) (5)
- Future prospects of research on central cholinergic mechanisms. (1990) (4)
- Upper and lower motor neuron disorders. (2003) (4)
- Erratum: (-)-Deprenyl protection of 1-methyl-4 phenylpyridium ion (MPP+)-induced apoptosis independent of MAO-B inhibition (Neuroscience Letters PII: S0304394097001705) (1997) (4)
- Specificity of biochemical and biophysical tests in Duchenne and myotonic muscular dystrophy, carrier states, and congenital myotonia. (1975) (4)
- Calcium binding proteins in selective vulnerability of motor neurons (2005) (4)
- Tregs Attenuate Peripheral Oxidative Stress and Acute Phase Proteins in ALS (2022) (4)
- Amyotrophic lateral sclerosis, frontotemporal lobar dementia, and p62 (2012) (4)
- Combined Regulatory T-Lymphocyte and IL-2 Treatment Is Safe, Tolerable, and Biologically Active for 1 Year in Persons With Amyotrophic Lateral Sclerosis (2022) (3)
- Amyotrophic lateral sclerosis mortality rates in Harris County, Texas. (1991) (3)
- Microglial activation and dopaminergic cell injury (2001) (3)
- Calcium-dependent hydrolyses of polyphosphoinositides in human erythrocyte membranes. (1984) (3)
- CELLULAR AND SUBCELLULAR FRACTIONATION OF BRAIN TISSUE. (1971) (3)
- Apoptosis induced by beta-N-oxalylamino-L-alanine on a motoneuron hybrid cell line. (1996) (3)
- Detection of endothelial cell-associated human DNA reveals transplanted human bone marrow stem cell engraftment into CNS capillaries of ALS mice (2021) (3)
- The Pathogenesis of Amyotrophic Lateral Sclerosis (2001) (3)
- Vimentin-crossreactive antibodies induce cell death in primary cultures of embryonic spinal cord (1993) (3)
- Role of Inflammation in Neurodegenerative Diseases (2015) (3)
- Mental status assessment of insight and judgment. (1989) (3)
- Will neurotrophic agents be harmful in Alzheimer's disease? (1989) (2)
- Letter: Muscular dystrophies. (1974) (2)
- Ex vivo expanded human regulatory T cells modify neuroinflammation in a preclinical model of Alzheimer’s disease (2022) (2)
- Macromolecular Synthesis in Synapses (1972) (2)
- ALS as an autoimmune disease (1991) (2)
- Coronary and Cerebral Vascular Disease: A Practical Guide to Management of Patients With Atherosclerotic Vascular Disease of the Heart and Brain (1989) (2)
- Serum programmed cell death proteins in amyotrophic lateral sclerosis (2021) (2)
- Beneficial Effects of Transplanted Human Bone Marrow Endothelial Progenitors on Functional and Cellular Components of Blood-Spinal Cord Barrier in ALS Mice (2021) (2)
- Design using historical controls (2004) (2)
- Inherited Membrane Disorders of Muscle (1986) (2)
- Calbindin D28K forms a Ca(2+)-dissociable complex with mellitin in vitro. (1996) (2)
- Protective and Toxic Neuroinflammation in Amyotrophic Lateral Sclerosis (2015) (2)
- Acetylcholine receptor turnover in myasthenia gravis. (1982) (2)
- Euthanasia and physician-assisted suicide in ALS: A commentary (2004) (2)
- Erratum: A novel N18TG2 x mesencephalon cell hybrid expresses properties that suggest a dopaminergic cell line of substantia nigra origin (J Neurosci (September 1992) 12 (3392-3393)) (1993) (2)
- Autoimmunity and ALS. Discussion (1996) (1)
- Is a breakdown of the blood-brain barrier cause or effect? (1986) (1)
- Immune-mediated cell death and neuroprotection in neurodegenerative diseases (1996) (1)
- Myotonic Muscular Dystrophy (1987) (1)
- Neurological Syndromes Associated with Alcohol (1980) (1)
- Alzheimer research forum live discussion: mice on trial? Issues in the design of drug studies. (2009) (1)
- Blood Serum Biomarkers for Differential Diagnosis of Parkinson’s Disease (2006) (1)
- The TREM2 Variant p.R47H is a Risk Factor for Sporadic Amyotrophic Lateral Sclerosis (I5-2.002) (2014) (1)
- Synapse function in vitro. (1968) (1)
- Novel therapeutic targets in neurodegenerative diseases: Lessons from amyotrophic lateral sclerosis (2008) (1)
- Neurological mutants of the mouse (meeting report). (1965) (1)
- Biochemical approaches to the study of synaptic function. (1970) (1)
- Reactive oxygen and nitrogen species - A driving force in amyotrophic lateral sclerosis (2012) (1)
- A Phase IIa Double-Blind, Placebo-Controlled Study to Evaluate the Safety of Oral Fingolimod In Patients with Amyotrophic Lateral Sclerosis (ALS) (P7.067) (2015) (1)
- Faculty Opinions recommendation of Mutant induced pluripotent stem cell lines recapitulate aspects of TDP-43 proteinopathies and reveal cell-specific vulnerability. (2012) (1)
- The differential in vitro stimulation of 3′,5′‐cyclic nucleotide phosphodiesterase by calcium binding proteins (1997) (1)
- Radicava/Edaravone Findings in Biomarkers From Amyotrophic Lateral Sclerosis (REFINE-ALS) (2020) (1)
- A study of the interaction between skeletal muscle acetylcholine receptor and concanavalin A (1975) (1)
- Biochemical approaches to dementia. (1977) (1)
- Section on Neurochemistry (1973) (1)
- An animal model of motor neuron disease in guinea pigs. (1990) (1)
- Trial of immunosuppression in amyotrophic lateral sclerosis using total lymphoid irradiation (1994) (1)
- Can Pyrimethamine Lower CSF SOD1 Levels in Familial ALS? Results from a Multicenter Phase Ib Trial (S43.007) (2016) (0)
- Phosphorylated TDP-43 (pTDP-43) aggregates in the axial skeletal muscle of patients with sporadic and familial amyotrophic lateral sclerosis (2018) (0)
- Poly (ADP-Ribose) Polymerase immunoreactivity in Motor Neurons and Astrocytes in the Spinal Cord of Sporadic Amyotrophic Lateral Sclerosis Patients. (2002) (0)
- Developmental changes in the incorporation in vitro of (3H) fucose in normal and deafferentiated optic tecta. (1973) (0)
- In reply [5] (2007) (0)
- lateral sclerosis . neuropsychological deficits in amyotrophic Prevalence and correlates of (2003) (0)
- Pilot trial of Cop 1 in chronic progressive multiple sclerosis: Preliminary report (1989) (0)
- Peter Kellaway, PhD (1920–2003) (2004) (0)
- Alzheimer's and Parkinson's disease: anatomical, pathological and biochemical aspects (1986) (0)
- The chemical plasticity of the brain: the role of messenger RNA and polysomes in neural function. (1966) (0)
- Diagnosis and Biochemical Mechanisms of Multiple Forms of Alzheimer's Disease Based on the Correlation of Apolipoprotein E Isoforms with the Differences in Serum Concentration of 45 Additional Protein Biomarkers (2010) (0)
- Book review. (1992) (0)
- Immunosuppressive Functions of M2 Macrophages Derived from iPSCs of ALS Patients (2020) (0)
- Immune-mediated Mechanisms in the Pathoprogression of Amyotrophic Lateral Sclerosis (2013) (0)
- Euthanasia and Physician-Assisted Suicide in ALS (2002) (0)
- Potential Immune Biomarkers for Disease Progression in ALS (P5.040) (2016) (0)
- Functional alterations of myeloid cells during the course of Alzheimer’s disease (2018) (0)
- Pathophysiology of membranes in myopathies (1983) (0)
- Faculty Opinions recommendation of Common molecular signature in SOD1 for both sporadic and familial amyotrophic lateral sclerosis. (2007) (0)
- Book Review:Advances in Neurochemistry. Volume 2. B. W. Agranoff, M. H. Aprison (1979) (0)
- United States Patent ( 19 ) Appel 54 DIAGNOSIS OF ALZHEIMER DISEASE 75 ) Inventor : 73 Assignee : (2017) (0)
- The Dissociation of Dysarthria from Cognitive Dysfunction in ALS (2005) (0)
- Ex-Vivo Regulatory T Cells Isolated from Patients with Amyotrophic Lateral Sclerosis Are Dysfunctional (S20.006) (2016) (0)
- Increased Neuronal and Glial Poly (ADP-Ribose) Polymerase Immunoreactivity in the Brain of Sporadic Amyotrophic Lateral Sclerosis (2002) (0)
- population survival and disease progression in an ALS clinic Forced vital capacity ( FVC ) as an indicator of (2006) (0)
- Oxidative stress-mediated inflammation promotes the pathogenesis of amyotrophic lateral sclerosis (2022) (0)
- AALSS (2004) (0)
- NONCONFORMING NERVE CELLS (1959) (0)
- iPSC-derived M2-like ALS macrophages suppress pro-Inflammatory phenotype of M1-like macrophages (S25.008) (2018) (0)
- A comparison of the αbungarotoxin binding to the acetylcholine receptor in different micro environments (1974) (0)
- A Tribute to Jenny S. Henkel, Ph.D. (1955–2013) (2013) (0)
- Macromolecular Characterization of Muscle Membranes (2011) (0)
- Autonomic Sudomotor Dysfunction in Alzheimers Disease (2003) (0)
- Spinal Cord and Motor Neuron TDP-43 Pathology in a Sporadic Inclusion Body Myositis Patient (2020) (0)
- [Trophic influence of motor neurons on the glycoproteins of the phasic and tonic muscles. I. NANA and hexosamines]. (1973) (0)
- Trophic and Modulating Factors for Basal Forebrain Cholinergic Neurons (1991) (0)
- Oral session 22—Motor neuron disease (2) (2005) (0)
- Carbohydrate metabolism of synapses. (1970) (0)
- New Approaches to Alzheimer’s Disease: Neurotrophic Factors (1985) (0)
- Amyotrophic lateral sclerosis: Can we predict the course of disease? (2006) (0)
- Comparison of Ml and M2 Muscarinic Acetylcholine Receptors Detergent‐Solubilized and Purified Preparations a (1987) (0)
- Microglial Morphology Is Not Altered by the Presence of RAN Proteins in the Cerebellar Cortex of ALS Patients (P6.228) (2016) (0)
- A Tribute to Jenny S. Henkel, Ph.D. (1955–2013) (2013) (0)
- The spectrum of altered cognition in amyotrophic lateral sclerosis (2006) (0)
- Regulatory T-lymphocytes mediate amyotrophic lateral sclerosis progression and survival (2013) (0)
- The role of blood brain barrier in the development of neuroimmunological diseases (1992) (0)
- Neuroinflammation co‐localizes highly with tau in amnestic mild cognitive impairment (2022) (0)
- Motor neuron biology, pathology and treatment of amyotrophic lateral sclerosis (2007) (0)
- Editorial Board (1991) (0)
- Faculty Opinions recommendation of SOD1 mutations disrupt redox-sensitive Rac regulation of NADPH oxidase in a familial ALS model. (2008) (0)
- TDP-43 pathology in the basal forebrain and hypothalamus of patients with amyotrophic lateral sclerosis (2014) (0)
- TDP43-Mediated Microglial Activation through NF-κB, AP-1 and NLRP3 Inflammasome (P02.172) (2013) (0)
- 162. Patients with amyotrophic lateral sclerosis have specific denervation patterns (2012) (0)
- Neuroimmunology of Amyotrophic Lateral Sclerosis (2014) (0)
- Differential diagnosis of neurodegenerative diseases using serum: A new paradigm (2009) (0)
- The potential contribution of the adaptive immune system in frontotemporal dementia (2022) (0)
- The interaction of myasthenic immunoglobulins and cholinergic agonists on acetylcholine receptors (AChRs) of rat myotubes (1980) (0)
- Survival and Disease Progression in SOD1 Familial ALS in North America (P3.185) (2016) (0)
- Plasmapheresis Improves the Suppressive Function of Regulatory T Cells in Patients with Fast-Progressing Amyotrophic Lateral Sclerosis (P3.183) (2016) (0)
- T Regulatory Cells Mediate ALS Progression and Survival (P02.166) (2013) (0)
- Immunologic Aspects of Amyotrophic Lateral Sclerosis (2014) (0)
- TARGETING ADAPTIVE IMMUNE SYSTEM IN ALZHEIMER’S DISEASE (2019) (0)
- ALS monocytes exhibit a pro-inflammatory gene expression (I11-1B) (2015) (0)
- Calcium Channel Autoantibodies and Amyotrophic Lateral Sclerosis (1996) (0)
- Restoring dysfunctional regulatory T cells through ex vivo expansion in Alzheimer disease (2020) (0)
- Soluble striatal extracts enhance the survival and maturation of mesencephalic dopaminergic neurons in vitro (1986) (0)
- Faculty Opinions recommendation of Reversal of RNA dominance by displacement of protein sequestered on triplet repeat RNA. (2009) (0)
- [Effects of denervation on muscle glycoproteins in rabbits]. (1973) (0)
- Brain white mater differences between normal subjects and ALS patients assessed by diffusion tensor imaging (2007) (0)
- A CHRONICLE OF ONE FAMILY??S QUEST TO CURE ALS: (2004) (0)
- Retrospective clinical validation of the use of protein biomarkers from banked patient sera for differential diagnosis of Alzheimer's disease (2010) (0)
- INCORPORATION OF [$sup 14$C]-GLUCOSAMINE INTO SYNAPTOSOMES IN VITRO. (1971) (0)
- Research in neuromuscular disease. (1982) (0)
- CHAPTER 49 Amyotrophic Lateral Sclerosis (2014) (0)
- Correction to: ‘Seeking a measure of clinically meaningful change in ALS’ (2014) (0)
- Earlier Disease Onset in Non-Caucasian Amyotrophic Lateral Sclerosis (ALS) Patients: Retrospective Analysis from Two Tertiary Centers (P5.088) (2016) (0)
- Distinct patterns of disease progression in SOD1-associated familial ALS: A study of 25 mutations. Pooled analysis of two trials of pyrimethamine in familial ALS. (S3.005) (2017) (0)
- Modulation of spontaneous motor unit potentials by a new motor cortical magnetic stimulation method in amyotrophic lateral sclerosis (2022) (0)
- Human Bone Marrow Endothelial Progenitor Cell Transplantation into Symptomatic ALS Mice Delays Disease Progression and Increases Motor Neuron Survival by Repairing Blood-Spinal Cord Barrier (2019) (0)
- Trophic Effects of Hippocampus Cell Membrane Fragments on Cultured Medial Septal Cholinergic Neurons (1990) (0)
- The Role of Regulatory T Cells and Microglia in Amyotrophic Lateral Sclerosis (2015) (0)
- Diagnosis and biochemical mechanisms of multiple forms of Alzheimer's disease based on the correlation of Apolipoprotein E isoforms with the differences in serum concentration of 45 additional protein biomarkers (2010) (0)
- Current Neurology, Vol. 17 (1997) (0)
- Ex vivo expansion of dysfunctional regulatory T lymphocytes restores suppressive function in Parkinson’s disease (2021) (0)
- Faculty Opinions recommendation of Wild-type and mutant SOD1 share an aberrant conformation and a common pathogenic pathway in ALS. (2010) (0)
- SCIENTIFIC PUBLICATIONS OF THE INSTITUTE OF BIOPHYSICS OF THE HUNGARIAN ACADEMY OF SCIENCES 2009 LABORATORY OF MEMBRANE BIOENERGETICS (2010) (0)
- Demyelinative and degenerative diseases of the nervous system. (1978) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Stanley H. Appel?
Stanley H. Appel is affiliated with the following schools:
